Evidence map›Paper›PMID 34973231›Full record

ArticleThe Lancet. Oncology2022

Radiographic progression-free survival in the ACIS trial for prostate cancer.

Ian F Tannock, Christopher M Booth, Bishal Gyawali, Anthony M Joshua

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ian F TannockDivision of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.
Christopher M BoothDivision of Cancer Care and Epidemiology, Department of Oncology, and Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
Bishal GyawaliDivision of Cancer Care and Epidemiology, Department of Oncology, and Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
Anthony M JoshuaDepartment of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic Neoplasms, Castration-ResistantHumansMaleProgression-Free Survival

Identifiers

PMID34973231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.